Faculty who have authored publication A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma.
Name | Title | Department | Institution |
---|---|---|---|
Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |